SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Jul 29, 2025
8-K Jun 18, 2025 FORM 8-K
4 Jun 13, 2025 OWNERSHIP DOCUMENT
DEFA14A Jun 10, 2025 DEFA14A
8-K Jun 6, 2025 FORM 8-K
4 Jun 2, 2025 OWNERSHIP DOCUMENT
4 May 22, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13G May 15, 2025
8-K May 13, 2025 8-K
10-Q May 13, 2025 10-Q
ARS Apr 23, 2025 ARS
DEFA14A Apr 23, 2025 DEFA14A
DEF 14A Apr 23, 2025 DEF 14A
8-K Mar 20, 2025 8-K
10-K Mar 20, 2025 10-K
424B5 Jan 29, 2025 424B5
8-K Jan 29, 2025 FORM 8-K
8-K Jan 23, 2025 FORM 8-K
8-K Jan 16, 2025 FORM 8-K
4 Jan 14, 2025 OWNERSHIP DOCUMENT
4 Jan 14, 2025 OWNERSHIP DOCUMENT
4 Jan 14, 2025 OWNERSHIP DOCUMENT
4 Jan 14, 2025 OWNERSHIP DOCUMENT
4 Jan 14, 2025 OWNERSHIP DOCUMENT
4 Jan 14, 2025 OWNERSHIP DOCUMENT
← Newer Page 3 of 51 · 1272 filings Older →